Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

Summary

The primary goal of this study is to characterize the pharmacokinetics of doxylamine succinate in children ages 2 to \< 18 years. Once characterized, these pediatric pharmacokinetic data will be pooled with historical adult PK data from other studies to assess whether the existing Over-the-Counter (OTC)doses provide comparable systemic drug exposure as that associated with efficacy in adults.

Timeline

Start

2008-12

Primary completion

2009-06

Completion

2009-06

Drugs

Indications